EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The role of renin-angiotensin system in patients with left ventricular assist devices

Alexandros Briasoulis iD, Ernesto Ruiz Duque, Dimitrios Mouselimis, Anastasios Tsarouchas, Constantinos Bakogiannis, Paulino Alvarez

Journal of the Renin-Angiotensin-Aldosterone System · 2020-10 · 21 (4)

DOI: 10.1177/1470320320966445 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the Renin-Angiotensin-Aldosterone System, online erschienen am 21.10.2020. Verfasst von Alexandros Briasoulis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Diseases, Section of Heart Failure and Transplant, University of Iowa Hospitals and Clinics, Iowa City, IA, USA. Hauptthemen laut MEDLINE: Heart-Assist Devices, Renin-Angiotensin System. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

End-stage heart failure is a condition in which the up-regulation of the systemic and local renin-angiotensin-aldosterone system (RAAS) leads to end-organ damage and is largely irreversible despite optimal medication. Left ventricular assist devices (LVADs) can downregulate RAAS activation by unloading the left ventricle and increasing the cardiac output translating into a better end-organ perfusion improving survival. However, the absence of pulsatility brought about by continuous-flow devices may variably trigger RAAS activation depending on left ventricular (LV) intrinsic contractility, the design and speed of the pump device. Moreover, the concept of myocardial recovery is being tested in clinical trials and in this setting LVAD support combined with intense RAAS inhibition can promote recovery and ensure maintenance of LV function after explantation. Blood pressure control on LVAD recipients is key to avoiding complications as gastrointestinal bleeding, pump thrombosis and stroke. Furthermore, emerging data highlight the role of RAAS antagonists as prevention of arteriovenous malformations that lead to gastrointestinal bleeds. Future studies should focus on the role of angiotensin receptor inhibitors in preventing myocardial fibrosis in patients with LVADs and examine in greater details the target blood pressure for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart-Assist DevicesRenin-Angiotensin SystemHeart FailureHeart VentriclesHumansHypertensionMyocardium

Stichwörter der Autor:innen

Heart failureLVADhypertensionrenin angiotensin system

Autor:innen und Institutionen

  • Division of Cardiovascular Diseases, Section of Heart Failure and Transplant, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
  • 3rd Department of Cardiology Hippocration Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

ORCID-Profile: Alexandros Briasoulis

Zitieren

APA

Briasoulis, A., Ruiz Duque, E., Mouselimis, D., Tsarouchas, A., Bakogiannis, C., & Alvarez, P. (2020). The role of renin-angiotensin system in patients with left ventricular assist devices. Journal of the Renin-Angiotensin-Aldosterone System, 21(4). https://doi.org/10.1177/1470320320966445

Vancouver

Briasoulis A, Ruiz Duque E, Mouselimis D, Tsarouchas A, Bakogiannis C, Alvarez P. The role of renin-angiotensin system in patients with left ventricular assist devices. Journal of the Renin-Angiotensin-Aldosterone System. 2020;21(4). doi:10.1177/1470320320966445

BibTeX
@article{Briasoulis2020,
  author = {Briasoulis, Alexandros and Ruiz Duque, Ernesto and Mouselimis, Dimitrios and Tsarouchas, Anastasios and Bakogiannis, Constantinos and Alvarez, Paulino},
  title = {The role of renin-angiotensin system in patients with left ventricular assist devices},
  journal = {Journal of the Renin-Angiotensin-Aldosterone System},
  year = {2020},
  volume = {21},
  number = {4},
  doi = {10.1177/1470320320966445}
}
Kostenlos starten →